Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
GKOS
#949
Glaukos Corporation
120.0
6
-1.27%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-1.27%
Monatliche Änderung
-1.47%
6 month change
+25.63%
Jahresänderung
+1.48%
Vorheriger Schlusskurs
121.6
0
Open
118.9
3
Bid
Ask
Low
118.7
2
High
120.0
6
Volumen
233
Märkte
Aktien
Gesundheitswesen
GKOS
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
45.79 M
47.05 M
47.88 M
49.47 M
56.57 M
58.08 M
—
Valuation ratios
Enterprise value
3.35 B
1.99 B
1.98 B
3.72 B
8.31 B
6.47 B
22.38 B
Price to earnings ratio
-27.87
-41.53
-21
-27.73
-54.13
-34.42
-196.3
Price to sales ratio
14.89
7.02
7.36
11.86
20.63
12.73
48.31
Price to cash flow ratio
-145.68
83.5
-62.93
-64.64
-129
-436.63
-1 041.35
Price to book ratio
5.02
3.51
3.93
8.08
10.31
9.84
15.04
Enterprise value to EBITDA ratio
-35.57
-619.85
-39.05
-39.14
-95.85
-132.95
-445
Profitability ratios
Return on assets %
0.12
0.05
0.1
0.14
0.15
0.21
0.2
Return on equity %
0.18
0.08
0.19
0.29
0.19
0.29
0.27
Return on invested capital %
80.32
23.95
48.3
65.48
65.48
108.46
101.55
Gross margin %
59.23
77.34
75.61
75.99
75.48
55.72
232.88
Operating margin %
54.92
11.18
29.1
40.89
31.91
39.33
147.65
EBITDA margin %
-41.86
-1.09
-17.94
-30.2
-22.61
-9.59
-38.83
Net margin %
53.5
16.87
35.07
42.8
38.18
36.99
138.39
Liquidity ratios
Quick ratio
9.13
7.31
5.61
4.78
5.22
4.06
18.84
Current ratio
9.45
7.67
6.13
5.34
5.99
4.69
21.88
Inventory turnover
3.14
3.43
2.27
1.89
1.89
1.84
1.8
Asset turnover
0.25
0.29
0.28
0.32
0.4
0.54
0.52
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.19
0.27
0.28
0.3
—
—
—
Long term debt to total equity ratio
0.28
0.48
0.53
0.61
—
—
—
Per share metrics
Operating cash flow per share
0.52
0.53
0.7
1.19
1.16
0.26
0.26
EBIT per share
-2.78
-0.71
-1.73
-2.66
-2.32
-1.52
-1.52
EBITDA per share
-2.12
-0.07
-1.07
-1.96
-1.64
-0.85
-0.85
Total debt per share
—
—
—
—
—
—
—
Cash per share
9.3
9.12
2.52
1.93
3.22
1.59
7.08
Net current asset value per share
10.55
10.47
9.36
8.17
8.53
8.31
31.7
Tangible book value per share
5.48
4.05
3.29
2.33
8.29
7.83
30.72
Working capital per share
9.43
9.11
7.83
6.64
7.1
6.53
25.81
Book value per share
15
12.65
11.17
9.53
14.54
11.47
51.74
Nachrichten
Stifel bekräftigt Kaufempfehlung für Glaukos dank Produktdynamik
Stifel reiterates Glaukos stock rating on product momentum
Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook
Wachstumstreiber iDose und Epioxa: Needham erhöht Kursziel für Glaukos
Needham raises Glaukos stock price target on iDose, Epioxa growth
These Analysts Boost Their Forecasts On Glaukos Following Q4 Results - Glaukos (NYSE:GKOS)
Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript
Glaukos (GKOS) Reports Q4 Earnings: What Key Metrics Have to Say
Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates
Glaukos vor Quartalszahlen: Markteinführungen von iDose und Epioxa im Fokus/n
Glaukos earnings on deck as iDose, Epioxa launches converge
Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth